Daniel E. Geraghty spends much of his time researching Human leukocyte antigen, Genetics, Molecular biology, Gene and HLA-E. In general Human leukocyte antigen, his work in Nomenclature Committee and Histocompatibility is often linked to Library science linking many areas of study. Genetics is represented through his Major histocompatibility complex, Allele, KIR2DS4, Gene family and Locus research.
His Molecular biology study incorporates themes from RNA, Biochemistry, Primary transcript, Alternative splicing and Peptide sequence. His biological study spans a wide range of topics, including Transfection, NKG2, Receptor, CD94/NKG2 and Peptide. His Receptor study combines topics from a wide range of disciplines, such as LILRB1 and Immunology.
His main research concerns Human leukocyte antigen, Genetics, Immunology, Gene and Haplotype. His Human leukocyte antigen research is multidisciplinary, incorporating elements of Molecular biology, Genotyping, Typing and Major histocompatibility complex. The study incorporates disciplines such as Cell culture, Trophoblast, HLA-G, Peptide binding and HLA-A in addition to Molecular biology.
His work carried out in the field of Immunology brings together such families of science as Receptor and Virology. Many of his research projects under Gene are closely connected to Chromosome 19 with Chromosome 19, tying the diverse disciplines of science together. His Haplotype research incorporates themes from Genetic association, Transplantation and HLA-C.
Human leukocyte antigen, Genetics, Haplotype, Allele and Gene are his primary areas of study. His Human leukocyte antigen research is included under the broader classification of Immunology. His Immunology research focuses on Receptor and how it connects with Antibody.
Daniel E. Geraghty combines subjects such as Odds ratio, Type 1 diabetes and Transplantation with his study of Genetics. As a member of one scientific family, Daniel E. Geraghty mostly works in the field of Haplotype, focusing on Genomics and, on occasion, Immunogenetics. His work on Human genome and Sequence analysis as part of general Gene research is frequently linked to Cholesterol binding and Motif, bridging the gap between disciplines.
His primary scientific interests are in Human leukocyte antigen, Immunology, Haplotype, HVTN 505 and Receptor. His Human leukocyte antigen course of study focuses on DNA sequencing and Loss of heterozygosity, Genotype and Typing. His Immunology study integrates concerns from other disciplines, such as Vector, Recombinant DNA, Sequence analysis and Virology.
His Haplotype study combines topics in areas such as Internal medicine, Single-nucleotide polymorphism and Massive parallel sequencing. His research on Receptor also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nomenclature for factors of the HLA system, 2010.
S G. E. Marsh;E. D. Albert;W. F. Bodmer;R. E. Bontrop.
Tissue Antigens (2010)
Complete sequence and gene map of a human major histocompatibility complex
S Beck;D Geraghty;H Inoko;L Rowen.
A second lineage of mammalian major histocompatibility complex class I genes
Seiamak Bahram;Maureen Bresnahan;Daniel E. Geraghty;Thomas Spies.
Proceedings of the National Academy of Sciences of the United States of America (1994)
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
Ni Lee;Manuel Llano;Marta Carretero;Akiko Ishitani.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Nomenclature for factors of the HLA system, 2004
Steven G.E. Marsh;E. D. Albert;W. F. Bodmer;R. E. Bontrop.
International Journal of Immunogenetics (2005)
Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.
Akiko Ishitani;Daniel E. Geraghty.
Proceedings of the National Academy of Sciences of the United States of America (1992)
A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I GENE THAT ENCODES A PROTEIN WITH A SHORTENED CYTOPLASMIC SEGMENT
Daniel E. Geraghty;Beverly H. Koller;Harry T. Orr.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley;Daniel J. Weisdorf;Lisbeth A. Guethlein;John P. Klein.
The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.
Katharine C. Hsu;Shohei Chida;Daniel E. Geraghty;Bo Dupont.
Immunological Reviews (2002)
A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.
Tomoyuki Fujii;Akiko Ishitani;Daniel E. Geraghty.
Journal of Immunology (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: